An antigen-specific cell therapy for autoimmune disease avoids compromising immunity as a whole.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ellebrecht, C.T. et al. Science 353, 179–184 (2016).
Bach, J.-F. N. Engl. J. Med. 347, 911–920 (2002).
Chatenoud, L. Curr. Opin. Pharmacol. 23, 92–97 (2015).
Hammers, C.M. et al. J. Invest. Dermatol. 135, 742–749 (2015).
Phillips, W.D. & Vincent, A. F1000 Res. 5, 1513 (2016).
Luo, J. et al. J. Neurosci. 29, 13898–13908 (2009).
Ambrosi, A., Sonesson, S.E. & Wahren-Herlenius, M. Exp. Cell Res. 325, 2–9 (2014).
Gleicher, N. & Elkayam, U. Autoimmun. Rev. 12, 1039–1045 (2013).
Skog, A., Lagnefeldt, L., Conner, P., Wahren-Herlenius, M. & Sonesson, S.E. Acta Obstet. Gynecol. Scand. 95, 98–105 (2016).
Serreze, D.V. et al. J. Exp. Med. 184, 2049–2053 (1996).
Pescovitz, M.D. et al. N. Engl. J. Med. 361, 2143–2152 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Chatenoud, L. Precision medicine for autoimmune disease. Nat Biotechnol 34, 930–932 (2016). https://doi.org/10.1038/nbt.3670
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3670